Apellis Pharmaceuticals, Inc. Business Finance Contracts & Agreements
25 Contracts & Agreements
- Exchange Agreements (6 contracts)
- Indenture Agreements (1)
- Investor Rights Agreements (2)
- Loan Agreements (1)
- Purchase Agreements (2)
- Stock Agreements (3)
- Underwriting Agreements (7)
- Warrant Agreements (3)
- Form of Pre-Funded Warrant (Filed With SEC on February 24, 2023)
- Underwriting Agreement, dated February 22, 2023, by and among the Company and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Evercore Group L.L.C (Filed With SEC on February 24, 2023)
- Form of Exchange Agreement (Filed With SEC on August 2, 2022)
- Form of Exchange Agreement (Filed With SEC on July 27, 2022)
- Underwriting Agreement, dated March 23, 2022, by and among the Company and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Evercore Group L.L.C (Filed With SEC on March 25, 2022)
- Underwriting Agreement, dated November 15, 2021, by and among the Company and J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC and Evercore Group L.L.C (Filed With SEC on November 17, 2021)
- Form of Exchange Agreement (Filed With SEC on July 8, 2021)
- Form of Exchange Agreement (Filed With SEC on January 7, 2021)
- Amendment No. 1 to 2017 Employee Stock Purchase Plan (Filed With SEC on November 2, 2020)
- Underwriting Agreement, dated January 8, 2020, by and among the Company and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Evercore Group L.L.C (Filed With SEC on January 9, 2020)
- Indenture (including form of Note), dated as of September 16, 2019, by and between Apellis Pharmaceuticals, Inc and U.S. Bank National Association, as trustee (Filed With SEC on September 16, 2019)
- Underwriting Agreement, dated March 6, 2019, by and among the Company and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Cowen and Company, LLC (Filed With SEC on March 7, 2019)
- Form of Underwriting Agreement (Filed With SEC on April 16, 2018)
- 2017 Employee Stock Purchase Plan (Filed With SEC on October 30, 2017)
- Specimen stock certificate evidencing the shares of common stock (Filed With SEC on October 27, 2017)
- Loan and Security Agreement, dated as of October 20, 2017, between the Registrant and Silicon Valley Bank (Filed With SEC on October 20, 2017)
- Warrant to purchase shares of common stock issued to Silicon Valley Bank (Filed With SEC on October 20, 2017)
- Warrant to purchase shares of common stock issued to Golda Darty Partners S.A (Filed With SEC on October 20, 2017)
- Form of Underwriting Agreement (Filed With SEC on October 20, 2017)
- Investors Rights Agreement, dated as of August 7, 2017, among the Registrant and the other parties thereto (Filed With SEC on October 13, 2017)
- Asset Purchase Agreement, dated as of September 24, 2014, by and between the Registrant and Potentia Pharmaceuticals, Inc (Filed With SEC on October 13, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITY OF PENNSYLVANIA Amended... (Filed With SEC on October 13, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITYof PENNSYLVANIA Patent... (Filed With SEC on October 13, 2015)
- INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on October 13, 2015)
- ASSET PURCHASE AGREEMENT dated September 24, 2014 between APELLISPHARMACEUTICALS, INC. and POTENTIA PHARMACEUTICALS, INC. TABLE OF CONTENTS (Filed With SEC on October 13, 2015)